Coverage
-
December 15, 2015
Pacira Pharmaceuticals Inc. said Tuesday it has settled its recent dispute with the U.S. Food and Drug Administration over the agency's allegedly inappropriate attempt to halt the company's off-label marketing of pain medication Exparel.
2 other articles on this case.
View all »